China Kangtai Cactus Biotech to Launch Patented Cactus-based Low Tar, Low or Zero Nicotine Cigarettes
Biotech Inc. (OTC Bulletin Board: CKGT), a vertically integrated grower,
developer, manufacturer and marketer of a variety of cactus-based products in
production of cactus-based cigarettes and plans to launch two products in the
forth quarter in 2009: (i) low nicotine and (ii) zero nicotine cigarettes. The
new patented cactus cigarettes, under the registered trademark “Shengcao”
brand, are expected to increase sales by approximately
The low nicotine cigarette is made from cactus, honeysuckle, ginkgo biloba
leaves and a small amount of tobacco leaves. This cactus-derived cigarette
lowers tar and nicotine content by 70%.
The zero nicotine cigarette is made without any tobacco leaves. It offers
taste and enjoyment equivalent to regular cigarettes, but eliminates nicotine.
It also greatly reduces harm related to secondhand smoke.
China Kangtai CEO
huge potential for growth in
accounting for 30% of global smokers. Our revolutionary product can not only
capture a significant portion of smokers, but also promote consumer
consumption in our other health products such as nutraceuticals, nutritious
food, health and energy drinks, beer, wine and liquor. We expect the launch of
our cactus health-preserving cigarettes also will improve the brand name and
reputation of our company.”
China Kangtai was awarded patents for these two cactus cigarettes from
2006100102091 and 2006100102087.
About China Kangtai Cactus Biotech Inc.
China Kangtai Cactus Biotech Inc. is a leading grower, developer, producer,
and marketer of cactus-derived products, including nutraceuticals, nutritious
food, health and energy drinks, beer, wine and liquor, extracts and powders,
and animal feed. China Kangtai controls over 387 acres of plants and maintains
an active R&D group that holds 18 product patents and is seeking another 12.
China Kangtai’s high-quality “green” products are sold throughout
distribution network that covers 12 of
four municipalities. More information may be found at http://www.biocactus.com
or via e-mail: email@example.com.
An investment profile on China Kangtai Cactus Biotech Inc. is available at
http://www.hawkassociates.com/profile/ckgt.cfm . For an online investor
relations kit, visit http://www.hawkassociates.com . For more investor-related
firstname.lastname@example.org. To subscribe to future releases via e-mail alert,
visit http://www.hawkassociates.com/about/alert/ .
This news release contains forward-looking statements as defined by the
Private Securities Litigation Reform Act of 1995. Forward-looking statements
include statements concerning plans, objectives, goals, strategies, future
events or performance, and underlying assumptions and other statements that
are other than statements of historical facts. These statements are subject to
uncertainties and risks including, but not limited to, product and service
demand and acceptance, changes in technology, economic conditions, the impact
of competition and pricing, government regulation, and other risks contained
in reports filed by the company with the Securities and Exchange Commission.
All such forward-looking statements, whether written or oral, and whether made
by or on behalf of the company, are expressly qualified by the cautionary
statements and any other cautionary statements which may accompany the
forward-looking statements. In addition, the company disclaims any obligation
to update any forward-looking statements to reflect events or circumstances
after the date hereof.
For more information, please contact: Hawk Associates Susan Zhou Tel: +1-305-451-1888 Email: email@example.com
SOURCE China Kangtai Cactus Biotech Inc.